Please try another search
Nanosphere, Inc. develops, manufactures, and markets molecular diagnostic tests for infectious diseases and associated drug resistance markers for earlier disease detection, optimal patient treatment, and improved healthcare economics. It offers a molecular diagnostics platform, Verigene System platform that enables sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation and single use consumable for on demand testing. The Verigene System is used for testing infectious disease assays, human and pharmacogenetic assays, and ultra-sensitive and multiplexed protein assays. The company focuses on serving hospital-based laboratories and academic research institutions in the United States. Nanosphere, Inc. was founded in 1998 and is headquartered in Northbrook, Illinois. As of June 29, 2016, Nanosphere, Inc. operates as a subsidiary of Luminex Corporation.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review